CompletedNCT00826202
D-serine as early support for schizophrenia symptoms
About this title
Read the official source — NCT00826202Medication studyAges 13–35United States
Understand this study
Who was this study for?
Listed age limits: 13 years to 35 years.
- Listed locations
- New Haven and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateMarch 2009
- Recruitment status
- Completed
- Enrollment listed in the registry
- 44
- Sponsor
- Nathan Kline Institute for Psychiatric Research
- Sponsor type
- Research institute
- Study type
- Drug
- Intervention type
- Drug, Other
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 13 Years to 35 Years
- Official registry ID
- NCT00826202
- Official title
Show the full official title
D-Serine vs Placebo for the Schizophrenia Prodrome
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
New Haven · Glen Oaks · New York
1 more locations
- Orangeburg
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Nathan Kline Institute for Psychiatric Research, a research institute.
Did this study involve medication?
Yes. The study involved medication, including D-serine.
Who was this study for?
Listed age limits: 13 years to 35 years.
